Cabaletta Bio, Inc. (CABA)
3.17
-0.01
(-0.31%)
USD |
NASDAQ |
Mar 06, 16:00
3.20
+0.03
(+0.95%)
After-Hours: 20:00
Cabaletta Bio Shareholders Equity (Quarterly) : 139.47M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Anavex Life Sciences Corp. | 126.62M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 94.39M |
| BioMarin Pharmaceutical, Inc. | 6.087B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 189.76M |
| Total Liabilities (Quarterly) | 50.29M |
| Debt to Equity Ratio | 0.1848 |
| Current Ratio | 3.598 |
| Net Debt Paydown Yield | -1.63% |